POLYPHOR – INNOVATION IN DRUG DISCOVERY
Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs.
These macrocycles represent a new drug class complementary to the classical small molecules and large biopharmaceuticals.
Our proprietary and unique technologies are broadly applicable to a wide array of biological targets and disease areas and provide innovative treatment options.
We leverage our technologies to develop our own product portfolio and to pursue licensing and collaboration opportunities.
September 1, 2015 – Polyphor extends clinical development portfolio...
March 17, 2015 - Polyphor appoints new CEO and strengthens executive management...
January 9, 2015 - Polyphor signs licensing agreement with PARI Pharma...
Hegenheimermattweg 125, CH-4123 Allschwil, Switzerland
Tel. +41 61 567 16 00, Fax +41 61 567 16 01, firstname.lastname@example.org
Last modified: 01.09.2015